Sandoz Group AG (SDZNY)

USD 40.79

(-0.22%)

Market Cap (In USD)

17.9 Billion

Revenue (In USD)

8.94 Billion

Net Income (In USD)

77 Million

Avg. Volume

48.37 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
27.79-46.8
PE
-
EPS
-
Beta Value
0.19384477
ISIN
US7999261008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Richard Saynor
Employee Count
-
Website
https://www.sandoz.com
Ipo Date
2023-10-04
Details
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.